Pilulka Lekarny AS (XPRA:PINK) Return-on-Tangible-Asset: 0.00% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPRA:PINK Pilulka Lekarny AS XPRA:PINK
48 GF Score
Price Kč121.00
GF Value Kč110.94
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Pilulka Lekarny AS Return-on-Tangible-Asset?

Pilulka Lekarny AS XPRA:PINK 48 Return-on-Tangible-Asset is 0.00% as of Dec. 2025. GuruFocus rates XPRA:PINK with a GF Score™ of 48/100 and a GF Value™ of Kč110.94 (Fairly Valued). The stock has 6 warning signs investors should review. Among 680 Healthcare Providers & Services companies, Pilulka Lekarny AS ranks worse than 80.44% on this metric.

Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Pilulka Lekarny AS's annualized Net Income for the quarter that ended in Dec. 2025 was Kč0 Mil. Pilulka Lekarny AS's average total tangible assets for the quarter that ended in Dec. 2025 was Kč186 Mil. Therefore, Pilulka Lekarny AS's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2025 was 0.00%.

The historical rank and industry rank for Pilulka Lekarny AS's Return-on-Tangible-Asset or its related term are showing as below:

XPRA:PINK' s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -44.07   Med: -16.78   Max: -4.92
Current: -20.85

During the past 6 years, Pilulka Lekarny AS's highest Return-on-Tangible-Asset was -4.92%. The lowest was -44.07%. And the median was -16.78%.

XPRA:PINK's Return-on-Tangible-Asset is ranked worse than
80.44% of 680 companies
in the Healthcare Providers & Services industry
Industry Median: 2.605 vs XPRA:PINK: -20.85

Pilulka Lekarny AS  (XPRA:PINK) Return-on-Tangible-Asset Explanation

Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.


Be Aware

Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the company’s earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a company’s tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.


Pilulka Lekarny AS Return-on-Tangible-Asset Related Terms


Pilulka Lekarny AS Return-on-Tangible-Asset Historical Data

* Premium members only.

The historical data trend for Pilulka Lekarny AS's Return-on-Tangible-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pilulka Lekarny AS Return-on-Tangible-Asset Chart

Pilulka Lekarny AS Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Return-on-Tangible-Asset
Get a 7-Day Free Trial -5.36 -12.70 -39.38 -44.07 -20.85

Pilulka Lekarny AS Semi-Annual Data
Dec20 Dec21 Dec22 Dec23 Jun24 Dec24 Dec25
Return-on-Tangible-Asset Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Pilulka Lekarny AS Return-on-Tangible-Asset Competitor Comparison

For the Pharmaceutical Retailers subindustry, Pilulka Lekarny AS's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pilulka Lekarny AS Return-on-Tangible-Asset vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pilulka Lekarny AS's Return-on-Tangible-Asset distribution charts can be found below:

* The bar in red indicates where Pilulka Lekarny AS's Return-on-Tangible-Asset falls into.


XPRA:PINK
48GF Score
Pilulka Lekarny AS XPRA:PINK
Return-on-Tangible-Asset is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pilulka Lekarny AS Return-on-Tangible-Asset Calculation

Pilulka Lekarny AS's annualized Return-on-Tangible-Asset for the fiscal year that ended in Dec. 2025 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=-38.869/( (198.334+174.438)/ 2 )
=-38.869/186.386
=-20.85 %

Pilulka Lekarny AS's annualized Return-on-Tangible-Asset for the quarter that ended in Dec. 2025 is calculated as:

Return-on-Tangible-Asset=Net Income/( (Total Tangible Assets+Total Tangible Assets)/ count )
(Q: Dec. 2025 )  (Q: Dec. 2024 )(Q: Dec. 2025 )
=Net Income/( (Total Assets - Intangible Assets+Total Assets - Intangible Assets)/ count )
(Q: Dec. 2025 )  (Q: Dec. 2024 )(Q: Dec. 2025 )
=0/( (198.334+174.438)/ 2 )
=0/186.386
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is two times the semi-annual (Dec. 2025) net income data.

What does a Return-on-Tangible-Asset of 0.00% mean?
Pilulka Lekarny AS (XPRA:PINK) has a Return-on-Tangible-Asset of 0.00% as of Dec. 2025. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Pilulka Lekarny AS and its competitors. According to the industry distribution chart, Pilulka Lekarny AS ranks #547 out of 680 companies in the Healthcare Providers & Services industry, placing it in the top 80.4%.
Is Pilulka Lekarny AS's Return-on-Tangible-Asset too high?
Pilulka Lekarny AS's current Return-on-Tangible-Asset is 0.00%. Based on the distribution chart, Pilulka Lekarny AS ranks #547 out of 680 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Pilulka Lekarny AS has a GF Score™ of 48/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pilulka Lekarny AS's Return-on-Tangible-Asset compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Pilulka Lekarny AS ranks #547 out of 680 companies for Return-on-Tangible-Asset. This places Pilulka Lekarny AS in the lower half of its industry. The industry median Return-on-Tangible-Asset is 2.61. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.61, based on 680 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Pilulka Lekarny AS and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Pilulka Lekarny AS's current Return-on-Tangible-Asset is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pilulka Lekarny AS stock overvalued right now?
Based on GuruFocus' analysis, Pilulka Lekarny AS (XPRA:PINK) is currently considered Fairly Valued. The stock's GF Value™ is Kč110.94, compared to a current price of Kč121.00 — trading 9.1% above its estimated fair value. The current Return-on-Tangible-Asset is 0.00%. Pilulka Lekarny AS's overall GF Score™ is 48/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Pilulka Lekarny AS (XPRA:PINK), the current Return-on-Tangible-Asset is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pilulka Lekarny AS (XPRA:PINK) Overvalued in 2026?

Based on GuruFocus' analysis, Pilulka Lekarny AS stock appears to be overvalued. The current stock price of Kč121.00 is trading 9.1% above its estimated GF Value™ of Kč110.94. GuruFocus considers Pilulka Lekarny AS to be Fairly Valued.

Key valuation signals for XPRA:PINK:

  • Return-on-Tangible-Asset: 0.00%
  • GF Value™: Kč110.94 vs. price of Kč121.00 (9.1% above fair value)
  • GF Score™: 48/100 with 6 warning signs

No single metric tells the full story. See the XPRA:PINK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pilulka Lekarny AS Business Description

Address Drahobejlova 1073/36, Prague, CZE, 190 00
Pilulka Lekarny AS operates an online pharmaceutical store by distribution of medicinal products. The store offers over-the-counter-drugs, dietary supplements, baby foods, mother care products, cosmetics, other prescription drugs, sport nutritional products, diagnostic test kits, orthopaedic supplies, first aid kits, and other related products.
48GF Score

Get the complete analysis for XPRA:PINK

Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Kč121.00
Price
Kč110.94
GF Value